Milà-Alomà, MartaAshton, Nicholas J.Shekari, MahnazSalvadó, GemmaOrtiz-Romero, PaulaMontoliu-Gaya, LaiaBenedet, Andrea L.Karikari, Thomas K.Lantero-Rodriguez, JuanVanmechelen, EugeenDay, Theresa A.González-Escalante, ArmandSánchez-Benavides, GonzaloMinguillon, CarolinaFauria, KarineMolinuevo, José LuisDage, Jeffrey L.Zetterberg, HenrikGispert, Juan DomingoSuárez-Calvet, MarcBlennow, Kaj2023-08-302023-08-302022Milà-Alomà M, Ashton NJ, Shekari M, et al. Publisher Correction: Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer's disease. Nat Med. 2022;28(9):1965. doi:10.1038/s41591-022-02037-1https://hdl.handle.net/1805/35244This corrects the article "Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s disease" in Nat Med, volume 28 on page 1797.en-USAttribution 4.0 InternationalPredictive markersAlzheimer's diseaseAmyloid beta-peptidesPositron-emission tomographyArticle